Search results
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Benzinga via Yahoo Finance· 1 hour agoThursday, Johnson & Johnson (NYSE:JNJ) agreed to acquire Proteologix Inc., a privately held...
Analyst Report: Johnson & Johnson
Morningstar Research via Yahoo Finance· 4 hours agoJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics ...
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 5 hours agoA month has gone by since the last earnings report for Johnson & Johnson (JNJ). Shares have added...
Johnson & Johnson to acquire Proteologix for $850 million
Reuters via Yahoo Finance· 8 hours agoProteologix's antibody PX128 is ready to enter early-stage development for moderate to severe atopic...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Johnson Investment Counsel Inc.
ETF DAILY NEWS· 1 day agoJohnson Investment Counsel Inc. cut its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 12.4% in the 4th quarter, ...
Evergreen Wealth Solutions LLC Sells 689 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoEvergreen Wealth Solutions LLC reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 10.0% during the fourth quarter, according to the company ...
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 3 days agoJohnson & Johnson (JNJ Quick QuoteJNJ - Free Report) is one of the stocks most watched by Zacks.com visitors lately. The Zacks Large Cap Pharmaceuticals ...
Catalyst Financial Partners LLC Trims Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoCatalyst Financial Partners LLC reduced its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 11.6% in the 4th quarter, according to its ...
Johnson & Johnson Strikes $850 Million Deal to Boost Dermatology Portfolio
Morningstar· 8 hours agoJohnson & Johnson has agreed to buy privately-held biotechnology company Proteologix for an initial $850 million in cash in a deal that bolsters the healthcare ...
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
The Motley Fool via AOL· 4 days agoMany healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend stock....
